Similar articles

• Identification of a cleavage site directing the immunochemical detection of molecular abnormalities in type IIA von Willebrand factor.

  Dent JA, Berkowitz SD, Ware J, Kasper CK, Ruggeri ZM. Dent JA, et al. Proc Natl Acad Sci U S A. 1990 Aug;87(16):6306-10. doi: 10.1073/pnas.87.16.6306. Proc Natl Acad Sci U S A. 1990. PMID: 2385594 Free PMC article.
• Diagnosis of subtype 2B von Willebrand disease in a patient with 2A phenotype of plasma von Willebrand factor.

  Gaucher C, de Romeuf C, Rauïs-Morret M, Corazza F, Fondu P, Mazurier C. Gaucher C, et al. Thromb Haemost. 1995 Apr;73(4):610-6. Thromb Haemost. 1995. PMID: 7495067
• Concentration of mRNA for von Willebrand factor in platelets of type I von Willebrand disease.

  Takenaka T, Kuribayashi K, Tsukiyama M, Nakamine H, Fukuhara Y, Kuno T. Takenaka T, et al. Clin Chim Acta. 1996 Feb 9;245(1):125-7. doi: 10.1016/0009-8981(95)06184-3. Clin Chim Acta. 1996. PMID: 8646811 No abstract available.
• Laboratory diagnosis of von Willebrand disease type 1/2E (2A subtype IIE), type 1 Vicenza and mild type 1 caused by mutations in the D3, D4, B1-B3 and C1-C2 domains of the von Willebrand factor gene. Role of von Willebrand factor multimers and the von Willebrand factor propeptide/antigen ratio.

  Gadisseur A, Berneman Z, Schroyens W, Michiels JJ. Gadisseur A, et al. Acta Haematol. 2009;121(2-3):128-38. doi: 10.1159/000214853. Epub 2009 Jun 8. Acta Haematol. 2009. PMID: 19506359 Review.
• Type 2 von Willebrand disease causing defective von Willebrand factor-dependent platelet function.

  Meyer D, Fressinaud E, Hilbert L, Ribba AS, Lavergne JM, Mazurier C. Meyer D, et al. Best Pract Res Clin Haematol. 2001 Jun;14(2):349-64. doi: 10.1053/beha.2001.0137. Best Pract Res Clin Haematol. 2001. PMID: 11686104 Review.